Journal
JOURNAL OF HEPATOLOGY
Volume 56, Issue 2, Pages 496-499Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2011.06.022
Keywords
Stem cell; Cell therapy; Liver disease
Categories
Funding
- Sir Jules Thorn Trust
- MRC
- Scottish Enterprise
- NIHR
- BBSRC
- Medical Research Council [G0802577, G0700711B] Funding Source: researchfish
- The Sir Jules Thorn Charitable Trust [07JTA] Funding Source: researchfish
- MRC [G0802577] Funding Source: UKRI
Ask authors/readers for more resources
There is an increasing range of potential applications of stem cells in liver diseases, with many clinical studies already undertaken. We identify four of the main areas which we propose stem cell therapy could be a realistic aim for in the future: (1) to improve regeneration and reduce scarring in liver cirrhosis by modulating the liver's own regenerative processes, (2) to down-regulate immune mediated liver damage, (3) supplying hepatocyte-like cells (HLCs) derived from stem cells for use in extracorporeal bioartificial liver machines, and (4) to use stem cell derived HLCs for cell transplantation to supplement or replace hepatocyte function. (C) 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available